Editorials

The optimal dosing of gemtuzumab ozagamicin: where to go from here?

Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands
Tor Vergata University Hospital, Rome, Italy
Vol. 101 No. 6 (2016): June, 2016 https://doi.org/10.3324/haematol.2016.145763